Ortendahl JD, Pulgar SJ, Mirakhur B, Cox D, Bentley TGK, & Phan AT. (2017). Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals. Dove Medical Press.
Chicago Style (17th ed.) CitationOrtendahl JD, Pulgar SJ, Mirakhur B, Cox D, Bentley TGK, and Phan AT. Budget Impact of Somatostatin Analogs as Treatment for Metastatic Gastroenteropancreatic Neuroendocrine Tumors in US Hospitals. Dove Medical Press, 2017.
MLA (9th ed.) CitationOrtendahl JD, et al. Budget Impact of Somatostatin Analogs as Treatment for Metastatic Gastroenteropancreatic Neuroendocrine Tumors in US Hospitals. Dove Medical Press, 2017.
Warning: These citations may not always be 100% accurate.